QingSong Health Corp (Ticker: 2661 HK) is a China-based company operating two core business lines: Qingsong Insurance, an internet insurance sales platform leveraging AI and big data to offer personalized products in collaboration with major insurers like PICC and Ping An; and Qingsong Healthcare, which provides comprehensive solutions including early disease screening, customized health packages, and medical research assistance. The company is scheduled to list on the Hong Kong Stock Exchange on December 23, 2025.

The company plans to offer 26.54 million shares at a fixed price of HKD 22.68, aiming to raise HKD 601.93 million (approximately USD 77.35 million). This pricing implies a market capitalization of roughly USD 601.45 million. Reportedly, QingSong Health intends to allocate 50% of the IPO proceeds to brand promotion and business development, 40% to R&D and product capacity expansion, and the remaining 10% to working capital and strategic acquisitions. The offering is sponsored by CICC and China Merchants Securities.